A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents
Clinical trial NCT03670667 · COMPLETED
Trial details
- NCT number
- NCT03670667
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-02-22
- Primary completion
- 2019-03-29
- Enrollment
- 1132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.